Dr Reddy’s responds to USFDA on quality issues

Highlights

City-based Dr Reddy\'s Laboratories on Wednesday said it had submitted a response to the US health regulator on a warning letter it had received last month.

Hyderabad: City-based Dr Reddy's Laboratories on Wednesday said it had submitted a response to the US health regulator on a warning letter it had received last month.

"We would like to inform that the company has submitted a response to the US Food and Drug Administration (USFDA) on December 7", the pharma major said in a release.

Last month, the company received a warning letter from the USFDA relating to quality control issues at two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana.

In the warning letter, the US health regulator had asked the drug maker to provide a comprehensive evaluation of the extent of inaccuracies in recorded and reported data and include a detailed action plan to fully investigate the scale and root causes of ‘deficient documentation and data management practices’.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
More Stories


Top